Clinical Trials Finder
This tool is for general information only and is not medical advice. Talk with your doctor before considering any clinical study. LocalRX.net does not run, sponsor, recruit for, or endorse any study listed here, and receives no payment from study sponsors. Study details can change; always confirm on ClinicalTrials.gov.
Recruiting clinical trials for Dupixent (24)
Eligibility is decided by the study team.
The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
Lead sponsor: Sanofi
North Richland Hills, Texas · ~40.1 mi
View official record on ClinicalTrials.govStudy contact
Trial Transparency Trial Transparency · 800-633-1610 option 6 · Contact-us@sanofi.com
Nearest study sites
The Lung & Sleep Institute of North Texas
North Richland Hills, Texas · ~40.1 mi
Neha Nair · 817-284-9225
Contact details are published by the study team on ClinicalTrials.gov; LocalRX is not affiliated with these studies.
A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis
Lead sponsor: Regeneron Pharmaceuticals
Fort Worth, Texas · ~48.5 mi
View official record on ClinicalTrials.govStudy contact
Clinical Trials Administrator · 844-734-6643 · clinicaltrials@regeneron.com
Study officials
Clinical Trial Management · Study Director · Regeneron Pharmaceuticals
Nearest study sites
Cook Children's Medical Center
Fort Worth, Texas · ~48.5 mi
Children's Hospital Colorado
Aurora, Colorado · ~646.6 mi
Contact details are published by the study team on ClinicalTrials.gov; LocalRX is not affiliated with these studies.
A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis
Lead sponsor: Sanofi
Austin, Texas · ~206.6 mi
View official record on ClinicalTrials.govStudy contact
Trial Transparency email recommended (Toll free for US & Canada) · 800-633-1610 ext. option 6 · contact-us@sanofi.com
Nearest study sites
Dell Children's Medical Center- Site Number : 8400007
Austin, Texas · ~206.6 mi
Vital Prospects Clinical Research Institute - Tulsa- Site Number : 8400002
Tulsa, Oklahoma · ~214 mi
Contact details are published by the study team on ClinicalTrials.gov; LocalRX is not affiliated with these studies.
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
Lead sponsor: Sanofi
Sugar Land, Texas · ~247.2 mi
View official record on ClinicalTrials.govStudy contact
Trial Transparency email recommended (Toll free number for US & Canada) · 800-633-1610 ext. option 6 · Contact-US@sanofi.com
Nearest study sites
Complete Dermatology - Site Number : 8400046
Sugar Land, Texas · ~247.2 mi
Tulane University School of Medicine- Site Number : 8400045
New Orleans, Louisiana · ~441.9 mi
Contact details are published by the study team on ClinicalTrials.gov; LocalRX is not affiliated with these studies.
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
Lead sponsor: Sanofi
Beaumont, Texas · ~255.2 mi
View official record on ClinicalTrials.govStudy contact
Trial Transparency email recommended (Toll free for US & Canada) · 800-633-1610 ext. option 6 · contact-us@sanofi.com
Nearest study sites
REX Clinical Trials - Beaumont- Site Number : 8400011
Beaumont, Texas · ~255.2 mi
University of Kansas Medical Center- Site Number : 8400005
Kansas City, Kansas · ~430.1 mi
Contact details are published by the study team on ClinicalTrials.gov; LocalRX is not affiliated with these studies.
Dupilumab Versus Topical Corticosteroid Effectiveness - Comparison in the Treatment of Stenotic EoE
Lead sponsor: University of Colorado, Denver
Aurora, Colorado · ~646.6 mi
View official record on ClinicalTrials.govStudy contact
Michelle Landis, BS · 720-777-8884 · michelle.landis@childrenscolorado.org
Nearest study sites
Children's Hospital Colorado/University of Colorado School of Medicine
Aurora, Colorado · ~646.6 mi
Clinical Research Supervisor | Digestive Health Institute · 720-777-8884
Contact details are published by the study team on ClinicalTrials.gov; LocalRX is not affiliated with these studies.
Olfactory Cleft Obstruction and Electrophysiological Field Potentials Predict Olfactory Restoration by Dupilumab in CRSwNP Patients.
Lead sponsor: Northwestern University
Chicago, Illinois · ~778.3 mi
View official record on ClinicalTrials.govStudy contact
Clinical Coordinator · 312 6958182 · aditi.agarwal@northwestern.edu
Bruce Tan, MD · 312 6958182 · btan@nm.org
Nearest study sites
Northwestern University Feinberg School of Medicine
Chicago, Illinois · ~778.3 mi
Aditi Agarwal, MBBS, MSCI · 312 6958182
Contact details are published by the study team on ClinicalTrials.gov; LocalRX is not affiliated with these studies.
Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin Disorders
Lead sponsor: Northwestern University
Chicago, Illinois · ~778.3 mi
View official record on ClinicalTrials.govStudy contact
Northwestern Dermatology CTU · 312-227-6817 · NUderm-research@northwestern.edu
Study officials
Amy Paller · Principal Investigator · Northwestern University
Nearest study sites
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois · ~778.3 mi
Dermatology CTU
Contact details are published by the study team on ClinicalTrials.gov; LocalRX is not affiliated with these studies.
Dupilumab in the Treatment of Pediatric Alopecia Areata
Lead sponsor: Icahn School of Medicine at Mount Sinai
Chicago, Illinois · ~778.3 mi
View official record on ClinicalTrials.govStudy contact
Benjamin Ungar, MD · 212-241-3288 · benjamin.ungar@mountsinai.org
Study officials
Emma Guttman-Yassky, MD, PhD · Principal Investigator · Icahn School of Medicine at Mount Sinai
Nearest study sites
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois · ~778.3 mi
Brian Cheng · 312-503-5911
Northwestern University Feinberg School of Medicine
Chicago, Illinois · ~778.3 mi
Brian Cheng · 312-503-5911
Contact details are published by the study team on ClinicalTrials.gov; LocalRX is not affiliated with these studies.
Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis
Lead sponsor: Northwestern University
Chicago, Illinois · ~778.3 mi
View official record on ClinicalTrials.govStudy contact
Dermatology CTU · 312-227-6817 · eczemasleepstudy@northwestern.edu
Study officials
Amy Paller, MD · Principal Investigator · Lurie Children's Hospital/Northwestern University
Nearest study sites
Lurie Children's Hospital/Northwestern University
Chicago, Illinois · ~778.3 mi
Contact details are published by the study team on ClinicalTrials.gov; LocalRX is not affiliated with these studies.
Ethnic Differences in Mechanisms of Action of Dupilumab
Lead sponsor: University of Michigan
Ann Arbor, Michigan · ~945.4 mi
View official record on ClinicalTrials.govStudy contact
Nicole Nechiporchik · 734-936-7519 · nnechipo@med.umich.edu
Study officials
Johann Gudjonsson, MD · Principal Investigator · University of Michigan
Nearest study sites
Contact details are published by the study team on ClinicalTrials.gov; LocalRX is not affiliated with these studies.
Dupixent in Adults With Refractory Post-Burn Pruritus in an Ambulatory Clinic
Lead sponsor: Akron Children's Hospital
Akron, Ohio · ~995.9 mi
View official record on ClinicalTrials.govStudy contact
ANJAY KHANDELWAL, MD · 330-543-4649 · akhandelwal@akronchildrens.org
Jessica Kracker, BSN · 330-543-0846 · jkracker@akronchildrens.org
Nearest study sites
Contact details are published by the study team on ClinicalTrials.gov; LocalRX is not affiliated with these studies.
Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
Lead sponsor: Sally E. Wenzel MD
Pittsburgh, Pennsylvania · ~1047.8 mi
View official record on ClinicalTrials.govStudy contact
John Moore · 412-648-6726 · mooreja6@upmc.edu
Nearest study sites
The University of Pittsburgh Asthma Institute at UPMC
Pittsburgh, Pennsylvania · ~1047.8 mi
Sally Wenzel, MD · 412-647-9955
Contact details are published by the study team on ClinicalTrials.gov; LocalRX is not affiliated with these studies.
Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNP
Lead sponsor: University of Virginia
Charlottesville, Virginia · ~1072.6 mi
View official record on ClinicalTrials.govStudy contact
Kristin W Wavell Shifflett, BS · 4349246874 · kww7d@virginia.edu
Deborah Murphy, BSN · 4349823510 · ddm9q@virginia.edu
Study officials
Larry C Borish, MD · Principal Investigator · University of Virginia
Nearest study sites
University of Virginia Health System
Charlottesville, Virginia · ~1072.6 mi
Deb Murphy, BSN · 434-982-3510
Contact details are published by the study team on ClinicalTrials.gov; LocalRX is not affiliated with these studies.
Dupilumab as Add-On Therapy for Hypereosinophilic Syndrome With Partial Clinical Response to Eosinophil-Depleting Biologic Agents
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Bethesda, Maryland · ~1160.6 mi
View official record on ClinicalTrials.govStudy contact
Amy D Klion, M.D. · (240) 381-6073 · amy.klion@nih.gov
Study officials
Amy D Klion, M.D. · Principal Investigator · National Institute of Allergy and Infectious Diseases (NIAID)
Nearest study sites
National Institutes of Health Clinical Center
Bethesda, Maryland · ~1160.6 mi
NIH Clinical Center Office of Patient Recruitment (OPR) · 800-411-1222 ext. TTY dial 711
Contact details are published by the study team on ClinicalTrials.gov; LocalRX is not affiliated with these studies.
Effect of Dupilumab on the Muscle Function of the Esophagus (food Pipe) in Participants with Eosinophilic Esophagitis (EoE)
Lead sponsor: University of California, San Diego
La Jolla, California · ~1195.9 mi
View official record on ClinicalTrials.govStudy contact
Anant Gupta, MBBS · 314-685-9214 · ucsdgimotility@gmail.com
Ravinder Mittal, MD · 858-534-3328 · rmittal@health.ucsd.edu
Nearest study sites
University of California San Diego (UCSD) Health Medical center
La Jolla, California · ~1195.9 mi
Anant Gupta, MBBS · 314-685-9214
Contact details are published by the study team on ClinicalTrials.gov; LocalRX is not affiliated with these studies.
Regeneron AA Multicenter (Dupilumab)
Lead sponsor: Emma Guttman
Irvine, California · ~1222.2 mi
View official record on ClinicalTrials.govStudy contact
Giselle Singer · 212-241-3288 · giselle.singer@mssm.edu
Sharlene Martin · 212-241-3288 · sharlene.martin@mssm.edu
Study officials
Emma Guttman-Yassky, MD, PhD · Principal Investigator · Icahn School of Medicine at Mount Sinai
Nearest study sites
Contact details are published by the study team on ClinicalTrials.gov; LocalRX is not affiliated with these studies.
This After Market Study is Seeing if Dupilumab Plus Usual Standard of Care (SOC) is Better Than Usual Care Alone for Adult Participants After a Severe Chronic Obstructive Pulmonary Disease (COPD) Flare-Up Requiring Hospitalization
Lead sponsor: Regeneron Pharmaceuticals
Mullica Hill, New Jersey · ~1270.7 mi
View official record on ClinicalTrials.govStudy contact
Clinical Trials Administrator · 844-734-6643 · clinicaltrials@regeneron.com
Study officials
Clinical Trial Management · Study Director · Regeneron Pharmaceuticals
Nearest study sites
Inspira Medical Center Mullica Hill
Mullica Hill, New Jersey · ~1270.7 mi
Contact details are published by the study team on ClinicalTrials.gov; LocalRX is not affiliated with these studies.
Dupixent and Narrowband UVB for Atopic Dermatitis
Lead sponsor: Psoriasis Treatment Center of Central New Jersey
East Windsor, New Jersey · ~1315 mi
View official record on ClinicalTrials.govStudy contact
Elise Nelson · 6094434500 · enelson@windsordermatology.com
Nearest study sites
Eczema Treatment Center of New Jersey
East Windsor, New Jersey · ~1315 mi
Elise Nelson · 609-443-4500 ext. 1402
Contact details are published by the study team on ClinicalTrials.gov; LocalRX is not affiliated with these studies.
A Real-world Study of Remibrutinib in Chronic Spontaneous Urticaria Patients
Lead sponsor: Novartis Pharmaceuticals
East Hanover, New Jersey · ~1334.3 mi
View official record on ClinicalTrials.govStudy contact
Novartis Pharmaceuticals · +41613241111 · novartis.email@novartis.com
Novartis Pharmaceuticals
Study officials
Novartis Pharmaceuticals · Study Director · Novartis Pharmaceuticals
Nearest study sites
Novartis
East Hanover, New Jersey · ~1334.3 mi
Contact details are published by the study team on ClinicalTrials.gov; LocalRX is not affiliated with these studies.
Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer
Lead sponsor: Rima Patel
New York, New York · ~1350.3 mi
View official record on ClinicalTrials.govStudy contact
Rima Patel, MD · (212) 604-6010 · Rima.Patel2@mssm.edu
Katherine Vandris · Katherine.Vandris@mssm.edu
Study officials
Rima Patel, MD · Principal Investigator · Icahn School of Medicine at Mount Sinai
Joseph Sparano, MD · Principal Investigator · Icahn School of Medicine at Mount Sinai
Nearest study sites
Mount Sinai Health System
New York, New York · ~1350.3 mi
Katherine Vandris
Contact details are published by the study team on ClinicalTrials.gov; LocalRX is not affiliated with these studies.
Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC
Lead sponsor: Icahn School of Medicine at Mount Sinai
New York, New York · ~1350.3 mi
View official record on ClinicalTrials.govStudy contact
Thomas Marron, MD, PhD · (212) 824-9472 · thomas.marron@mssm.edu
Katherine Vandris · Katherine.Vandris@mssm.edu
Study officials
Thomas Marron, MD, PhD · Principal Investigator · Icahn School of Medicine at Mount Sinai
Nearest study sites
Icahn School of Medicine at Mount Sinai
New York, New York · ~1350.3 mi
Thomas Marron, MD PhD · (212) 824-9472
Contact details are published by the study team on ClinicalTrials.gov; LocalRX is not affiliated with these studies.
Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases
Lead sponsor: Dan Feng
New York, New York · ~1350.3 mi
View official record on ClinicalTrials.govStudy contact
Lisa Fitzgerald · (917) 748-0962 · lisa.fitzgerald@mssm.edu
Rashmi Unawane · (212) 824-2385 · rashmi.unawane@mssm.edu
Study officials
Dan Feng, MD, PhD · Principal Investigator · Icahn School of Medicine at Mount Sinai
Thomas Marron, MD, PhD · Study Chair · Icahn School of Medicine at Mount Sinai
Nearest study sites
Icahn School of Medicine at Mount Sinai
New York, New York · ~1350.3 mi
Lisa Fitzgerald · (917) 748-0962
Contact details are published by the study team on ClinicalTrials.gov; LocalRX is not affiliated with these studies.
Molecular Signatures of Cutaneous Dupilumab Response
Lead sponsor: University of California, San Francisco
San Francisco, California · ~1483.2 mi
View official record on ClinicalTrials.govStudy contact
Jeffrey Cheng, MD, PhD · 415 575 0524 · rashes@ucsf.edu
Study officials
Jeffrey Cheng, MD, PhD · Principal Investigator · University of California, San Francisco
Raymond Cho, MD, PhD · Principal Investigator · University of California, San Francisco
Nearest study sites
University of California, San Francisco
San Francisco, California · ~1483.2 mi
Jeffrey Cheng, MD, PhD
Contact details are published by the study team on ClinicalTrials.gov; LocalRX is not affiliated with these studies.
Data from ClinicalTrials.gov, retrieved October 28, 2026.
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Data processed by ClinicalTrials.gov on 2026-10-28T09:00:04. LocalRX shows a shortened summary of each record; see the official record for complete details.